Mandisa Singata-Madliki to Burkina Faso
This is a "connection" page, showing publications Mandisa Singata-Madliki has written about Burkina Faso.
Connection Strength
0,131
-
Growth, clinical and neurodevelopmental outcomes at school age are similar for children who received 1-year lamivudine or lopinavir/ritonavir HIV prophylaxis in early life. Sci Rep. 2021 02 04; 11(1):3173.
Score: 0,047
-
Lopinavir-Ritonavir Impairs Adrenal Function in Infants. Clin Infect Dis. 2020 08 14; 71(4):1030-1039.
Score: 0,046
-
HIV-1 disease progression in immune-competent HIV-1-infected and breastfeeding mothers participating in the ANRS 12174 clinical trial in Burkina Faso, South Africa, Uganda and Zambia: a cohort study. BMJ Open. 2018 04 05; 8(4):e019239.
Score: 0,039